Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole vs Standard of Care in Schizophrenia (STAR)
NCT00237913Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jul 2004
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 3, randomised, open-label trial in schizophrenia comparing Aripiprazole with Standard of Care (2 arms). Primary endpoint: Investigator Assessment Questionnaire at 26 weeks. Started Jul 2004; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00237913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237913.